{"id":3731,"date":"2021-01-28T22:00:38","date_gmt":"2021-01-28T19:00:38","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=3731"},"modified":"2021-01-29T10:25:19","modified_gmt":"2021-01-29T07:25:19","slug":"novavax-covid-19-asisi-ingilteredeki-faz-3-denemesinde-89-3-etkili-bulundu","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/novavax-covid-19-asisi-ingilteredeki-faz-3-denemesinde-89-3-etkili-bulundu\/","title":{"rendered":"Novavax COVID-19 A\u015f\u0131s\u0131, \u0130ngiltere&#8217;deki Faz 3 Denemesinde % 89.3 Etkili Bulundu"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-100995 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2021\/01\/Novavax.jpg\" alt=\"\" width=\"120\" height=\"30\" \/><strong>Novavax biyoteknoloji firmas\u0131n\u0131n a\u00e7\u0131klamas\u0131na g\u00f6re, yeni a\u015f\u0131 virusun hem \u0130ngiltere hem de G\u00fcney Afrika varyantlar\u0131na kar\u015f\u0131 klinik etkilili\u011fi g\u00f6sterilen ilk a\u015f\u0131d\u0131r.<\/strong><\/p>\n<p>Ciddi bula\u015f\u0131c\u0131 hastal\u0131klar i\u00e7in yeni nesil a\u015f\u0131lar geli\u015ftiren bir biyoteknoloji \u015firketi olan Novavax, protein bazl\u0131 COVID-19 a\u015f\u0131 aday\u0131 NVX-CoV2373&#8217;\u00fcn birincil sonlan\u0131m noktalar\u0131n\u0131 kar\u015f\u0131layarak, Birle\u015fik Krall\u0131k&#8217;ta y\u00fcr\u00fct\u00fclen Faz 3 klinik ara\u015ft\u0131rmas\u0131n\u0131n sonu\u00e7lar\u0131na g\u00f6re % 89.3 etkili oldu\u011funu duyurdu. 18-84 ya\u015f aras\u0131 15 binden fazla kat\u0131l\u0131mc\u0131yla y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmada kat\u0131l\u0131mc\u0131lar\u0131n %27&#8217;sinin 65 ya\u015f \u00fczeri bireyler oldu\u011fu a\u00e7\u0131kland\u0131.<\/p>\n<p>\u00c7al\u0131\u015fmada, bula\u015fman\u0131n y\u00fcksek oldu\u011fu ve virusun \u0130ngiltere varyant\u0131n\u0131n ortaya \u00e7\u0131k\u0131p h\u0131zla yay\u0131ld\u0131\u011f\u0131 bir d\u00f6nem boyunca a\u015f\u0131n\u0131n etkilili\u011fi de\u011ferlendirildi. \u00c7al\u0131\u015fma, Birle\u015fik Krall\u0131k h\u00fckemetinin A\u015f\u0131 G\u00f6rev Komitesi ile ortakla\u015fa y\u00fcr\u00fct\u00fcld\u00fc. Novavax, ayr\u0131ca G\u00fcney Afrika&#8217;da y\u00fcr\u00fctt\u00fc\u011f\u00fc Faz 2b \u00e7al\u0131\u015fmas\u0131n\u0131n ba\u015far\u0131l\u0131 sonu\u00e7lar\u0131n\u0131 da a\u00e7\u0131klad\u0131.<\/p>\n<p><a href=\"https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3\"><strong>Bas\u0131n Duyurusu \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novavax biyoteknoloji firmas\u0131n\u0131n a\u00e7\u0131klamas\u0131na g\u00f6re, yeni a\u015f\u0131 virusun hem \u0130ngiltere hem de G\u00fcney Afrika varyantlar\u0131na kar\u015f\u0131 klinik etkilili\u011fi g\u00f6sterilen ilk a\u015f\u0131d\u0131r. Ciddi bula\u015f\u0131c\u0131 hastal\u0131klar i\u00e7in yeni nesil a\u015f\u0131lar geli\u015ftiren bir biyoteknoloji \u015firketi olan Novavax, protein bazl\u0131 COVID-19 a\u015f\u0131 aday\u0131 NVX-CoV2373&#8217;\u00fcn birincil sonlan\u0131m noktalar\u0131n\u0131 kar\u015f\u0131layarak, Birle\u015fik Krall\u0131k&#8217;ta y\u00fcr\u00fct\u00fclen Faz 3 klinik ara\u015ft\u0131rmas\u0131n\u0131n sonu\u00e7lar\u0131na g\u00f6re % 89.3 etkili oldu\u011funu duyurdu. 18-84 ya\u015f aras\u0131 15 binden fazla kat\u0131l\u0131mc\u0131yla y\u00fcr\u00fct\u00fclen \u00e7al\u0131\u015fmada kat\u0131l\u0131mc\u0131lar\u0131n %27&#8217;sinin 65 ya\u015f \u00fczeri bireyler oldu\u011fu a\u00e7\u0131kland\u0131. \u00c7al\u0131\u015fmada, bula\u015fman\u0131n y\u00fcksek oldu\u011fu ve virusun \u0130ngiltere varyant\u0131n\u0131n ortaya \u00e7\u0131k\u0131p h\u0131zla yay\u0131ld\u0131\u011f\u0131 bir d\u00f6nem boyunca a\u015f\u0131n\u0131n etkilili\u011fi de\u011ferlendirildi. \u00c7al\u0131\u015fma, Birle\u015fik Krall\u0131k h\u00fckemetinin A\u015f\u0131 G\u00f6rev Komitesi [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":3732,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/3731"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=3731"}],"version-history":[{"count":6,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/3731\/revisions"}],"predecessor-version":[{"id":3738,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/3731\/revisions\/3738"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/3732"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=3731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=3731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=3731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}